Drug Profile
PM 523
Latest Information Update: 22 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antivirals; Inorganic chemicals; Small molecules
- Mechanism of Action Viral fusion protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 22 Jun 2001 No-Development-Reported for Influenza virus infections in Japan (Unknown route)
- 19 May 1998 Preclinical development for Influenza virus infections in Japan (Unknown route)